This Combined Synopsis/Solicitation opportunity from Department Of Justice was posted on May 28, 2026. The submission period has ended. Browse the details below for market research, or find similar active opportunities.
Synthesis of Drugs/Chemical Substances
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
Active Opportunities Like This One
AI Contract Overview
The Drug Enforcement Administration’s Office of Diversion Control is seeking qualified small businesses to provide synthesis of specific drugs and chemical substances under a combined synopsis/solicitation designated as a 100% Small Business Set-Aside, with the NAICS code 541380 and a size standard of $41.5 million. This procurement, identified by solicitation number 15DDHQ26P00000584, was amended on May 28, 2026, to revise the scope from DNA testing to the synthesis of eight specified chemical compounds in one-gram quantities, including Ethylflualprazolam, Etodezitramide, Spiroborphine, 2-Methyl-alpha-PiHP, Bezitramide, 4F-PV8, 5,6-Dichloro Brorphine (SR-14968), and 4-propanoyloxy-N,N-dimethyltryptamine, with an additional line item for shipping. Performance is required in West Palm Beach, Florida, and offers are due by 10:00 a.m. EST on June 5, 2026. Evaluation will follow a Lowest Price Technically Acceptable (LPTA) approach, where technical acceptability is a pass/fail gate based on the offeror’s demonstrated ability to synthesize all specified items, and award will be made to the lowest-priced responsible offeror meeting all technical requirements. The contract incorporates numerous FAR clauses related to labor standards, equal opportunity, accelerated payments to small business subcontractors, prohibitions on contracting with inverted domestic corporations, and protections under the Fair Labor Standards Act. The work involves access to classified National Security Information and Controlled Unclassified Information, requiring compliance with DOJ security protocols and potential security clearance requirements. Offerors must maintain current representations and certifications in SAM.gov and comply with Buy American Act provisions, traffick in persons prohibitions, and organizational conflict of interest disclosure obligations. All deliverables, including reports and materials, must be packaged in accordance with common commercial practices and clearly labeled with the contract number. Invoicing must follow strict requirements, including submission of itemized charges, delivery dates, taxpayer identification, and supporting documentation for travel, with payment due thirty days after deemed acceptance and disputed charges resolved through the FAR 52.212-4(d) Disputes clause. The Contracting Officer is Kenny Douangmala, and the
General Info
Agency
NAICS
Place of Performance
West Palm Beach, FL, USASet-Aside
Timeline
Submission Closed
Organization & Contact Information
Full Description
1. This is a combined synopsis/solicitation for commercial items prepared in accordance with the format in Subpart 12.6, as supplemented with additional information included in this notice. This announcement constitutes the only solicitation; quotes are being requested and a written solicitation will not be issued.
2. This notice incorporates provisions and clauses in effect through Drug Enforcement Administration (DEA) Clause Matrix updated through FAC 2024-02. The complete text of any of the clauses and provisions may be accessed in full text at www.acquisition.gov.
3. This Combined Synopsis/Solicitation is 100% Small Business Set-Aside. The associated North American Industrial Classification System (NAICS) code for this procurement is 541380 - Testing Laboratories and Services with a business size standard of $41.5 Million.
_____________________________________________________________________________________________________
AMENDMENT 01 - 5/28/2026
Revises the description on page 1; #4;
From: DEA has a requirement for a contractor to provide DNA Testing.
To: DEA has a requirement for a contractor to provide synthesis of drugs/chemical substances.
All other terms and conditions remain the same and in full force and effect.
See Attachment for more details.
Find Active Opportunities Like This
Get AI-powered intelligence on the opportunities still open
Every page of the solicitation package shredded into a compliance breakdown
AI-powered matching based on your capabilities and past performance
Competitor and incumbent history on the requirement
Automated alerts on amendments, Q&A deadlines, and award
Join 650+ contractors already using CLEATUS
